| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/26/2009 | WO2009025520A2 Water-purifying apparatus generating anions and processing method thereof |
| 02/26/2009 | WO2009025398A1 Decellularizing solution, method of preparing decellularized tissue, graft and culture member |
| 02/26/2009 | WO2009025196A1 Foxm1 peptide and medicinal agent comprising the same |
| 02/26/2009 | WO2009025091A1 Pharmaceutical composition for treatment of fibromyalgia |
| 02/26/2009 | WO2009024429A2 Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria |
| 02/26/2009 | WO2009024340A1 Method of producing homologous celular blood components from hematopoietic progenitor cells |
| 02/26/2009 | WO2009009620A3 Acellular tissue matrix compositions for tissue repair |
| 02/26/2009 | WO2009002106A3 Anti-cancer composition comprising aquatic microbial extract |
| 02/26/2009 | WO2008140621A3 Transgenic oncolytic viruses and uses thereof |
| 02/26/2009 | US20090054364 treating bladder cancer; transfecting with polynucleotide into urothelial cells; improved transfection efficiency with cationic lipids, cationic polymers or dendrimers; improve drug delivery with a solubilized cholesterol |
| 02/26/2009 | US20090053805 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 02/26/2009 | US20090053802 Multipotent stem cells from peripheral tissues and uses thereof |
| 02/26/2009 | US20090053342 Preparation of microbial oil |
| 02/26/2009 | US20090053319 Sore Throat Relief Composition And Method of Producing Same |
| 02/26/2009 | US20090053296 Using cell-mediated immune response to e6 and e7 peptides as diagnostic/prognostic indication of recurrence and/or development of cervical intraepithelial neoplasia (CIN) |
| 02/26/2009 | US20090053295 Regulatable fusion promoters |
| 02/26/2009 | US20090053292 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 02/26/2009 | US20090053279 Tissue regenerative composition |
| 02/26/2009 | US20090053277 Cell Sheet Containing Mesenchymal Stem Cells |
| 02/26/2009 | US20090053271 Reverse-Phase Microcapsules for Actice Ingredients, Simplified Process of Manufacture Thereof and Combined Formulation Wdg- Cs,Zc, Ec-Sc, and Cx |
| 02/26/2009 | US20090053266 Apicomplex vaccine strains of a family of sarcocystidae |
| 02/26/2009 | US20090053264 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 02/26/2009 | US20090053244 Modified vaccinia virus strains for use in diagnostic and therapeutic methods |
| 02/26/2009 | US20090053208 Methods and Systems for Improving Tissue Perfusion |
| 02/26/2009 | US20090053199 Stable Dairy Components Effective for Fat Loss |
| 02/26/2009 | US20090053198 Cytokine Induction of Selectin Ligands on Cells |
| 02/26/2009 | US20090053187 Agent exhibiting bactericidal action with respect to vegetative and spore cells bacillus anthrasis, anthrax preventing and treating method |
| 02/26/2009 | US20090053186 Therapy for primary and metastatic cancers |
| 02/26/2009 | US20090053184 Compositions comprising t cell receptors and methods of use thereof |
| 02/26/2009 | US20090053183 Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro |
| 02/26/2009 | US20090053182 Endometrial stem cells and methods of making and using same |
| 02/26/2009 | US20090053181 Modulation of Cells |
| 02/26/2009 | US20090053180 Tandem cardiac pacemaker system |
| 02/26/2009 | US20090053179 Method for using liberated dormant bacteriophage and environmental stress to reduce infectious bacteria |
| 02/26/2009 | US20090053178 Use of herpes vectors for tumor therapy |
| 02/26/2009 | US20090053171 Treatment of cellular proliferative disorders |
| 02/26/2009 | US20090053144 Reduction in bacterial colonization by administering bacteriophage compositions |
| 02/26/2009 | US20090053136 Therapeutic immunoglobulin specific for lymphocyte adhesion protein for killing and/or inhibiting growth of cancer cells |
| 02/26/2009 | DE102007039429A1 Verfahren zur Aktivierung regulatorischer T-Zellen A process for the activation of regulatory T cells |
| 02/26/2009 | CA2696801A1 Generation of neuronal cells from pluripotent stem cells |
| 02/26/2009 | CA2696597A1 Foxm1 peptide and medicinal agent comprising the same |
| 02/25/2009 | EP2028270A2 Modified recombinant vaccina viruses and uses thereof |
| 02/25/2009 | EP2028269A1 Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or Exendin-4 and uses thereof |
| 02/25/2009 | EP2028267A1 Method of producing homologous cellular blood components from hematopoietic progenitor cells |
| 02/25/2009 | EP2028266A1 Method of producing lymphocytes |
| 02/25/2009 | EP2028190A1 Compounds and methods for therapy and diagnosis of lung cancer |
| 02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
| 02/25/2009 | EP2027872A1 Neurotoxic component of a botulinum toxin for treating a facial disease |
| 02/25/2009 | EP2027866A1 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 02/25/2009 | EP2027865A1 Liposome having lipid membrane containing bacterial cell component |
| 02/25/2009 | EP2027864A1 Composition for improvement of lipid metabolism |
| 02/25/2009 | EP2027263A1 Process for separating and determining the viral load in a pancreatin sample |
| 02/25/2009 | EP2027150A1 Allorestricted peptide-specific t cells |
| 02/25/2009 | EP2026835A1 Nasal and buccal compositions for controlling snoring |
| 02/25/2009 | EP2026824A2 Multifunctional blood substitute |
| 02/25/2009 | EP1680067B1 Composition for the cosmetic treatment of age-related dermatological symptoms |
| 02/25/2009 | EP1642963B1 Lactobacillus casei lc2w strain and its use in antihypertensive aspect |
| 02/25/2009 | EP1301795B1 Method of identifying and/or isolating stem cells |
| 02/25/2009 | EP1240326B1 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify this receptor |
| 02/25/2009 | CN101374946A Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation |
| 02/25/2009 | CN101374945A Immunophenotype and immunogenicity of human adipose derived cells |
| 02/25/2009 | CN101374855A Purification and use of a factor for supporting wound healing |
| 02/25/2009 | CN101374571A Na/K-ATPase ligand |
| 02/25/2009 | CN101374538A Pharmaceutical for promoting functional regeneration of damaged tissue |
| 02/25/2009 | CN101374533A Use of selected lactic acid bacteria for reducing infantile colic |
| 02/25/2009 | CN101371917A Brain protein hydrolysate sodium chloride injection and preparation method thereof |
| 02/25/2009 | CN101371912A Chinese medicine oral decoction for treating dysmenorrhea |
| 02/25/2009 | CN101371909A Medicine for treating carcinoma of stomach and preparation method thereof |
| 02/25/2009 | CN101371908A Gelatin-coated pill for preventing and treating calculi in vivo |
| 02/25/2009 | CN101371907A Ultra-high biomass all-around ordered high biological activity immunoincompetence disease Chinese medicine preparation |
| 02/25/2009 | CN101371906A Ultra-high biomass ordered high biological activity multi-polymer Chinese medicine preparation |
| 02/25/2009 | CN101371903A Orally taken Chinese medicinal composition for treating angioneurotic headache |
| 02/25/2009 | CN101371902A Effect of natural active glycogen for reducing blood sugar and blood fat |
| 02/25/2009 | CN101371898A Pollen cathartic medicine |
| 02/25/2009 | CN101371896A Pharmaceutical formulation for treating endometriosis symptom and processes for their preparation |
| 02/25/2009 | CN101371895A Pollen medicine for causing laxation |
| 02/25/2009 | CN101371894A Pollen medicine for lack of appetite |
| 02/25/2009 | CN101371893A Pollen hydragogue medicine |
| 02/25/2009 | CN101371892A Pollen medicine for causing vomiting |
| 02/25/2009 | CN101371890A Medicaments composite for treating gland hyperplasia and breast cancer and preparation method thereof |
| 02/25/2009 | CN101371880A Chinese medicinal composition for treating empyrosis wound surface |
| 02/25/2009 | CN101371871A Echinacea purpurea five-component oral spray |
| 02/25/2009 | CN101371868A Chinese medicine preparation for treating aplastic anemia |
| 02/25/2009 | CN101371853A Use of small intestine SP cells in preparing medicament for treating damage of intestines |
| 02/25/2009 | CN101371848A Medicament for treating burn and scald |
| 02/25/2009 | CN100464566C Method and equipment of changed digital color image |
| 02/25/2009 | CN100463955C Extraction method of effective ingredients from ants |
| 02/25/2009 | CN100463692C Chinses medicinal capsule for treating aplastic anemia |
| 02/25/2009 | CN100463687C Medicine for treating mammary gland diseases, and its preparation method |
| 02/25/2009 | CN100463682C Egg white activity extraction extracting and activity measuring technique |
| 02/24/2009 | US7494984 Substituted imidazo[1,2-a]pyrimidines as HIV viral DNA integrase inhibitors |
| 02/24/2009 | US7494812 Transforming lymphocytes with vector comprising gene sequences which code cytolethal distending toxin (cdt), leukotoxins and heat shock protein and generating regulatory cell which can be used to treat and/or prevent transplant rejection, autoimmune and inflammatory diseases; immunotherapy |
| 02/24/2009 | US7494808 Methods and interferon deficient substrates for the propagation of viruses |
| 02/24/2009 | US7494807 Nutrient broth for propagation of hematopoietic stem cells |
| 02/24/2009 | US7494799 Paramunity inducers based on attenuated rabbit myxoma virus |
| 02/24/2009 | US7494661 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 02/24/2009 | US7494657 Inhibitor of hepatitis B and HIV activity |
| 02/24/2009 | US7494644 contacting a myocardial cells with genetic engineered mammalian cells modified to express a connexin 43 proteins, to establishing electrical coupling between cardiomyocytes and recombinant cells; treatment of cardiac disease or tissue repair |
| 02/24/2009 | CA2360437C Method of acquiring immunological tolerance |
| 02/24/2009 | CA2286655C Tissue decellularization |